Accu-Chek Inform II Training Guide

PHSA Laboratories CW Site - Point of Care
Title: CWPC_GLU_0140 Accu-Chek Inform II Training Guide
Medical Approval: Dr Benjamin Jung Medical Approval Date: 27 Dec 2016
Version: 1.2 Implementation Date: 7/2/2019 11:55:59 PM
Folder Name: CW\Point of Care\Whole Blood Glucose
This is a controlled document for CW use only. Any printed copies are uncontrolled unless specified. Please refer to Lab QMS
Page 11 of 12
AccuChek Inform II Test Strip Limitations:
Galactose
Elevated Galactose can occur in neonates with inherited galactosemia (1 per
40,000 in BC).
First glucose value for neonates > 5.5 mmol/L is checked
simultaneously with a lab glucose during first 5 days of life.
(Collect a lab draw prior to next scheduled feed).
 Clinical assessment of patient important to identify neonatal galactosemia.
 Use a Lab Draw to confirm any unexpected high neonate glucose result. Consult
with physician.
 During the treatment of parenterally galactose containing drugs:
(eg. Echovist and Levovist) Send to lab, or repeat the test after the half-life of
drug.
Triglycerides – interference if > 20 mmol/L
 far beyond average values
 Concentrations above 5.7 mmol/L are considered very high.
 An extremely low number of people have concentrations of 20 mmol/L or higher.
Ascorbic Acid – interference if > 0.17 mmol/L
ICU patients receiving high dose IV ascorbic acid as support
Questions & Inform II Competency Checklist
 When the Competency Checklist is completed by the operators, please collect.
 Return to Point of Care Testing Office at the end of the day for record keeping.
Note: @ PHSA there is a Presentation with a Quiz to view on the Learning Hub. Part of
the certification process.

Accu-Chek Inform II Specifications

General

Sample Size	0.6 µL
Test Time	5 seconds
Memory Capacity	1000 test results
Display	LCD
Measurement Range	10 to 600 mg/dL
Connectivity	Infrared
Sample Type	Capillary whole blood
Operating Temperature	16 to 32°C (61 to 90°F)
Relative Humidity	10 to 90% non-condensing